Loading company…
Nevia Bio develops an AI-based diagnostic platform for early detection and prevention of ovarian cancer.
Founded in 2015 and based in Haifa, Israel, Nevia Bio, formerly Gina Life, develops a diagnostic platform for women's health, including early detection of ovarian cancer. Its AI and machine learning system analyzes vaginal discharge samples and compares them with a dataset. Co-founded by Shlomit Yehudai-Reshef and Inbal Zafir-Lavie, the company raised 1.9 million in pre-seed funding in August 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in